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ABSTRACT Olive leaves are rich in polyphenolic compounds that are known to have antioxidant, antimicrobial, and anti-
inflammatory activities. Therefore, olive leaf extract (OLE) is considered as a natural supplement. In this study we evaluated
the antibacterial and the anti-inflammatory effect of OLE and its individual phenolic components in vitro. Polymorphonuclear
cells (PMNCs) were isolated from the whole blood using Histopaque solution and cultured in RPMI-enriched medium. Tumor
necrosis factor a (TNFa) level was determined by ELISA after 24 h of lipopolysaccharide stimulation. The antibacterial
activity of OLE was determined by well diffusion assay. We found a significant decrease in TNFa secretion level in PMNCs
culture treated with OLE. Oleuropein is the only OLE component that has shown anti-inflammatory effects at a concentration
of 20 lg/mL. Furthermore, OLE exhibited antibacterial activity against some gram positive bacterial strains; however, gram
negative bacterial strains were resistant to OLE. Downregulation of TNFa secretion in PMNCs culture in response to OLE
treatment indicates that this polyphenol-rich extract has an anti-inflammatory effect, and oleuropein is the major OLE
component responsible for this effect. The antibacterial activity of OLE is limited to gram positive bacteria.
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INTRODUCTION
The cultivation of olive trees (Olea europaea) andthe production of olive oil have been a very crucial
farming practice in the Mediterranean region, which dates
back to ancient times. The average annual consumption of
olive oil in that area varies between 0.5 and 15 kg/person,1
where the Mediterranean diet has been known to be pro-
tective against cancer and coronary heart disease.2,3
Olive leaf extract (OLE) is a liquid obtained from the
leaves of the olive tree, which has been marketed as a nat-
ural supplement for multiple health benefits, such as its
antioxidant activity, which results in cardioprotective and
chemoprotective effects.4 In addition to that, OLE has an-
timicrobial activities, which may help in treatment of vari-
ous infectious diseases.5,6 Several compounds have been
found in OLE, altogether known as olive biphenols, which
are primarily responsible for its therapeutic activities.
Oleuropein is the most abundant biphenol in OLE, whereas
other biphenols are present in lower quantities.7
Reported epidemiological studies suggest that intake of
olive products might influence disease intensity and preva-
lence.8–10 For instance, the mortality rate from colorectal
cancer is lower in countries such as Spain where olive oil
intake is high than in countries such as England where the
olive oil intake is low.11 Owing to geographical location and
variation in plant nutrition, OLE might have a different
composition depending on where it is coming from.
Therefore, it is essential to find out the connection between
OLE individual components (Fig. 1) and their physiological
therapeutic effects. In this study, the primary focus was on
comparing between the anti-inflammatory and the antibac-
terial effects of OLE and its individual components.
MATERIALS AND METHODS
Individual compounds of OLE
Liquid solutions of biphenolic OLE compounds tyrosol,
catechin, gallic acid, and vanillic acid were purchased from
Sigma Aldrich (St. Louis, MO, USA). Oleuropein liquid solu-
tion was purchased fromMerck &Co. (Kenilworth, NJ, USA).
Olive leaf crude extract
Olive leaves were obtained from Nabali cultivar (Ra-
mallah, Palestine), dried at 30C, then ground with a blender.
Five grams of the ground extract was exposed to 50mL of
absolute ethanol for 3 h at 40C. The liquid extract was filtered
through suction filtration, followed by evaporation by using a
rotary evaporator, and crude OLE was finally obtained.
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Soybean–casein digest broth (TSB) has been prepared
according to manufacturer instructions and autoclaved at
121C for 15min.
Evaluation of antibacterial activities
Clinical strains of Staphylococcus aureus, Staphylococcus
epedermidis, Pseudomonas aeruginosa, and Escherichia coli
were kindly provided by the microbiology department of
Al-Quds University ( Jerusalem, Palestine). Mueller–Hinton
agar plates were used to evaluate the antimicrobial activity
of the OLE and results were compared with neomycin as
a control. Well diffusion assay was performed according
to National Committee for Clinical Laboratory Standards
(NCCLS; 1993). Thirteen micrograms of both the OLE and
neomycin was added to different wells, zone of inhibition of
bacterial growth was measured after 24 h of incubation at
37C (NCCLS, 1993).
Blood sample processing
Human blood sample was collected, after signing a consent
form from the donor, in two separate sets (6mL each) and saved
in K2-EDTA tubes. Polymorphonuclear cells (PMNCs) were
isolated from whole blood and cultured as described earlier.12
Cytotoxicity of OLE
Cell viability was tested by trypan blue exclusion assay.13
OLE was added to PMNCs culture at a concentration of
320 lg/mL for 16 h after stimulation with 1lg/mL of lipo-
polysaccharide (LPS). Results were compared with control
cell culture with or without LPS stimulation.
Evaluation of anti-inflammatory activities of OLE
and its phenolic compounds
Cultured PMNCs were stimulated with 1lg/mL LPS and
exposed to different concentrations of OLE as well as its in-
dividual phenolic compounds. Secreted tumor necrosis factor
a (TNFa) level was detected by TNFa detection ELISA kit
(R&D Systems, MN, USA), according to manufacturer’s
instructions.
Statistical analysis
Values were analyzed for significance using paired t-test.
SPSS software version 19 was used. P-value < .05 was con-
sidered significant.
RESULTS
OLE has no cytotoxic effects
OLE at a concentration of 320lg/mL showed no signif-
icant effect on PMNCs cell viability compared with cell
culture with or without LPS stimulation. Results are illus-
trated in Table 1.
Anti-inflammatory activity of OLE
and its phenolic compounds
The OLE had a significant inhibitory activity on TNFa
production followed by LPS stimulation at a concentration-
dependent manner (Table 2). When we tested the individual
OLE compounds separately, we found that only oleuropein
has a significant inhibitory effect of TNFa production at a
concentration of 20lg/mL. The other compounds did not
show any significant inhibitory effect at concentration as
high as 50lg/mL except gallic acid (Table 3).
Antibacterial activity
We compared the antibacterial activity of OLE to neo-
mycin against four clinical bacterial strains. OLE has
shown an antibacterial activity similar to neomycin against
FIG. 1. Structures of individual olive leaf extract
phenolic compounds. (A) Tyrosol, (B) catechin, (C)
gallic acid, (D) vanillic acid, (E) oleuropein.
Table 1. Effect of Olive Leaf Extract (320 lg/mL)
on Polymorphonuclear Cells Viability
Contents Viability P
PMNCs only 96.1 – 1.5
PMNCs with LPS only 94.2 – 2.1 >.05
PMNCs with LPS and OLE 93.4 – 2.4 >.05
Results are expressed as average– standard deviation (n = 3).
LPS, lipopolysaccharide; OLE, olive leaf extract; PMNCs, polymorphonu-
clear cells.

















































S. aureus and S. epedermidis. However, there was no anti-
bacterial activity of OLE detected against P. aeruginosa and
E. coli. Data are illustrated in Table 4.
DISCUSSION
Olive leaves contain a very limited amount of oleic acid
with a significant quantity of polyphenols, which gives OLE
a unique approach to study the effects of polyphenolic
content of olive oil and olive products in general.14 One of
the major phytochemical compounds present in large
quantities in OLE is oleuropein, which can be hydrolyzed to
hydroxytyrosol, oleuropein aglycone, elenolic acid, and
glucose.15,16 Studies have shown that oleuropein exhibits
many pharmacological activities in vitro, including anti-
inflammatory and antioxidants effects.16,17 Interestingly,
similar effects were noticed in vivo, wherein oleuropein and
its major metabolite have enhanced nitric oxide production,
decreased blood pressure, inhibited platelet aggregation, and
reduced infarct size in animal models.18–20
In this study, our aim was to determine which individual
phenolic component of OLE will have the most anti-
inflammatory effect compared with OLE overall. We found
a significant inhibition of TNFa secretion from PMNCs
upon OLE treatment at concentration of 80lg/mL after LPS
stimulation. TNFa level has reached 0.6– 0.1 pg/mL when
higher concentration of OLE (320 lg/mL) was used, which
is consistent with what have been reported before.21
Oleuropein is the only individual component that exhibited a
significant level of TNFa secretion once we tested OLE
components separately at 20lg/mL. When higher concen-
trations were used (50 lg/mL), gallic acid showed a sig-
nificant inhibition of TNFa secretion, whereas the effect of
other components was not significant. Furthermore, OLE
did not show any cytotoxic effects to PMNCs.
Finally, we have shown that OLE at the same concen-
tration as neomycin (13lg/well) had a similar antibacterial
effect against gram positive bacteria (S. aureus and S. epe-
dermidis), whereas gram negative bacteria (P. aeruginosa
and E. coli) were resistant to OLE treatment.
In conclusion, this work has shown that OLE has anti-
inflammatory and some antibacterial effects. Oleuropein is
the major compound in OLE that is responsible for its anti-
inflammatory effect. Thus, the purified major compound
oleuropein from OLE can potentially be used for further
pharmacological applications. In addition to that, a better
understanding of how pathogens respond to OLE will con-
tribute to using it as a preservation compound especially
against foodborne pathogens.
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